Medline Financials - Benzinga

Medline Inc

MDLNNASDAQ

Trade with Public

Trade with Public

$34.70

0.040.12%

近くで: Sep 25, 5:00 PM EST

$34.97

0.270.78%

時間外: Sep 25, 7:19 PM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Medline Financials

Medline (MDLN) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Medline Q2 Adj. EPS $0.50 Beats $0.32 Estimate, Sales $7.685B Beat $7.512B Estimate

Medline (NASDAQ:MDLN) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.32 by 56.25 percent. The company reported quarterly sales of $7.685 billion which beat the analyst

Benzinga Newsdesk

Earnings Scheduled For May 6, 2026

Benzinga Insights

PRO
Medline Sees FY26 Organic Sales Growth 8.5% To 9.5%

Benzinga Newsdesk

PRO
Medline Q1 EPS $0.33 Beats $0.23 Estimate, Sales $7.400B Beat $7.163B Estimate

Medline (NASDAQ:MDLN) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.23 by 43.48 percent. The company reported quarterly sales of $7.400 billion which beat the analyst

Benzinga Newsdesk

Medline Analysts Boost Their Forecasts Following Q4 Results

Avi Kapoor

PRO
Medline Q4 EPS $(0.01) Misses $0.18 Estimate, Sales $7.787B Beat $7.547B Estimate

Medline (NASDAQ:MDLN) reported quarterly losses of $(0.01) per share which missed the analyst consensus estimate of $0.18 by 105.49 percent. The company reported quarterly sales of $7.787 billion which beat the analyst

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved